Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Phase 2 Type 2 Diabetes Trial The Lancet (2023) A parallel Phase 2 trial published in The Lancet assessed retatrutide in 281 participants with type 2 diabetes over 36 weeks
Instruct patients to contact their healthcare provider if they have severe or persistent gastrointestinal symptoms [see Warnings and Precautions (5.5)]
Low-appetite emergency plan For days when eating feels nearly impossible: Shake 1 (morning): Protein shake, 25g protein Shake 2 (afternoon): Protein shake, 25g protein Small meal (evening): 4 oz chicken in bone broth soup, 26g protein Bedtime: 1 cup cottage cheese, 28g protein Total: 104 grams of protein on a bare minimum intake day Even on your worst appetite days, this framework keeps you above the critical threshold for muscle preservation
Although retatrutide is not yet available outside of clinical trials, understanding the warning signs of degradation is important for anyone handling the investigational product
What the Numbers Showed The gap appeared on both measures the trial was built around
US$ 24.62
US$ 21.47
US$ 23.33
US$ 23.85
.png)
US$ 27.10
